Synaptogenix Net Debt To E B I T D A from 2010 to 2024

SNPX Stock  USD 2.88  0.02  0.69%   
Synaptogenix Net Debt To EBITDA yearly trend continues to be fairly stable with very little volatility. Net Debt To EBITDA is likely to outpace its year average in 2024. Net Debt To EBITDA is a leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). View All Fundamentals
 
Net Debt To EBITDA  
First Reported
2010-12-31
Previous Quarter
3.45007209
Current Value
3.62
Quarterly Volatility
0.76445244
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Synaptogenix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Synaptogenix's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 1.6 M or Interest Income of 1.6 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.21 or PTB Ratio of 0.12. Synaptogenix financial statements analysis is a perfect complement when working with Synaptogenix Valuation or Volatility modules.
  
Check out the analysis of Synaptogenix Correlation against competitors.
For more information on how to buy Synaptogenix Stock please use our How to Invest in Synaptogenix guide.

Latest Synaptogenix's Net Debt To E B I T D A Growth Pattern

Below is the plot of the Net Debt To E B I T D A of Synaptogenix over the last few years. It is a leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). Synaptogenix's Net Debt To EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Synaptogenix's overall financial position and show how it may be relating to other accounts over time.
Net Debt To E B I T D A10 Years Trend
Very volatile
   Net Debt To E B I T D A   
       Timeline  

Synaptogenix Net Debt To E B I T D A Regression Statistics

Arithmetic Mean2.49
Geometric Mean2.30
Coefficient Of Variation30.73
Mean Deviation0.47
Median2.62
Standard Deviation0.76
Sample Variance0.58
Range3.1003
R-Value0.03
Mean Square Error0.63
R-Squared0
Significance0.91
Slope0.01
Total Sum of Squares8.18

Synaptogenix Net Debt To E B I T D A History

2024 3.62
2023 3.45
2022 2.32
2021 2.71
2020 0.52
2019 1.12

About Synaptogenix Financial Statements

Synaptogenix investors use historical fundamental indicators, such as Synaptogenix's Net Debt To E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Synaptogenix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Debt To EBITDA 3.45  3.62 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Synaptogenix Stock Analysis

When running Synaptogenix's price analysis, check to measure Synaptogenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synaptogenix is operating at the current time. Most of Synaptogenix's value examination focuses on studying past and present price action to predict the probability of Synaptogenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synaptogenix's price. Additionally, you may evaluate how the addition of Synaptogenix to your portfolios can decrease your overall portfolio volatility.